3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Other neoplasm
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Thoracic
1
Sarcoma
1
NET
1
Myeloid
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Multiple Endocrine Neoplasia Type 1
96
Pituitary Neoplasms
57
Neuroendocrine Tumors
50
Thyroid Cancer, Papillary
42
Thyroid Neoplasms
16
Obesity
15
Pheochromocytoma
14
Overweight
11
Adrenal Gland Neoplasms
10
Weight Loss
9
Paraganglioma
9
Carcinoma, Neuroendocrine
9
Pancreatic Neoplasms
8
Prostatic Neoplasms
7
Motor Activity
7
Insulinoma
7
Gastrointestinal Neoplasms
7
Brain Neoplasms
7
Adrenocortical Adenoma
7
Acquired Immunodeficiency Syndrome
7
Neoplasm Metastasis
6
Hyperaldosteronism
6
Carcinoma, Medullary
6
Stomach Neoplasms
5
Osteoporosis
5
Neoplasms
5
Meningioma
5
Liver Neoplasms
5
Insulin Resistance
5
HIV Infections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms, Glandular and Epithelial
×
Endocrine
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled